Promising
Apigenin
The prediction game
Call it: rising or fading?
Where does Apigenin stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: C (mixed evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.7/10
Apigenin is a 5/10 fit for people who want a gentle calming option, not a heavy sleep drug or a longevity shortcut. The best human signal still comes from chamomile extract trials, where apigenin is one active flavonoid among many: [Amsterdam 2009](https://pubmed.ncbi.nlm.nih.gov/19593179/) found a modest generalized-anxiety benefit, and [Mao 2016](https://pubmed.ncbi.nlm.nih.gov/27912875/) supports longer-term symptom reduction without a clean relapse-prevention win. Sleep evidence is weaker, with [Adib-Hajbaghery 2017](https://europepmc.org/article/med/29154054) pointing to chamomile extract in older adults rather than isolated apigenin capsules. The practical read is simple: Apigenin belongs after the basics, works best for anxious or sleep-fragile responders, and deserves extra caution with sedatives, anticoagulants, pregnancy, allergies, or chronic high-dose use. ✅ Best for: Anxious-baseline adults who want a gentle GABAergic calming option and are not using sedatives or anticoagulants. Chamomile responders who want to compare tea, standardized extract, and isolated apigenin. People building a sleep stack who are willing to test magnesium and theanine first, then add 25-50 mg apigenin only if needed. GAD-profile users closer to the chamomile trial populations in Mao 2016 and Amsterdam 2009. Careful self-experimenters interested in CD38/NAD+ who understand Escande 2013 is not human validation. ❌ Avoid if: You are a healthy low-anxiety user expecting a sleep transformation from 50 mg. You prioritize daytime emotional vitality and have a history of anhedonia, low motivation, or poor response to GABAergic compounds. You have Asteraceae or ragweed-family allergy. You take warfarin, narrow-therapeutic-index anticoagulants, benzodiazepines, Z-drugs, gabapentin, alcohol-heavy evening protocols, or other sedatives without clinician review. You are pregnant, lactating, preparing for surgery, or managing estrogen-sensitive disease. You are taking apigenin mainly for testosterone, aromatase inhibition, cancer prevention, or NAD+ longevity claims that remain preclinical or in vitro.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 9.1%
- BioHarmony Score
- 6.7/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.